Linuvia Tablets 100 mg (Sitagliptin Phosphate Hydrate)
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Medica Korea Co., Ltd.
MFDS item code 201502305 · Approved 2015.04.16
This product's status changed to Expired on 2025.04.16. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used alongside diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It may be used as monotherapy as initial treatment, and if blood sugar control is difficult with monotherapy, it may be used in combination with metformin. Additionally, it can be administered as an adjunct therapy when sufficient blood sugar control is not achieved with monotherapy of sulfonylurea, metformin, thiazolidinedione, or insulin. Even in cases requiring complex combination therapy, this medication aids effective blood sugar management. Therefore, this medication effectively improves blood sugar control in patients with type 2 diabetes.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. (See Precautions for Use, 5. General Precautions.) Patients with renal impairment As dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or patients with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.
This medication may cause serious allergic reactions in some patients. Such reactions can occur within the first 3 months after taking the medication, so if symptoms such as skin rashes, difficulty breathing, or swelling of the face or neck appear, discontinue use immediately and consult a physician. While taking this medication, acute pancreatitis may occur, so inform medical personnel immediately if symptoms such as abdominal pain, vomiting, or nausea occur. This medication should not be used by patients with type 1 diabetes or those with diabetic ketoacidosis. Additionally, it should not be taken by those who are allergic to this drug or its components. Patients with decreased kidney function may experience delayed excretion of this medication, so dosage adjustments are necessary and should be taken as directed by a physician. This medication may cause hypoglycemia when used alone or in combination with other diabetes treatments, so blood sugar levels should be carefully monitored, especially when taken with insulin or sulfonylureas. Some patients may experience severe joint pain, and if symptoms are severe or persist, medication should be discontinued and a physician consulted. Rarely, blistering skin conditions may occur, so inform medical personnel immediately if blisters or skin irritation appear. This medication generally has few drug interactions, but it is advisable to consult a physician when taking it with certain medications. It is safest for pregnant or breastfeeding women to avoid this medication, and it is not recommended for children under 18 years of age. Elderly patients should have regular kidney function tests before and after taking the medication, as kidney function may decline. In the event of overdose, general treatment and, if necessary, dialysis may be considered, so it is important to adhere to the prescribed dosage. Overall, this medication does not significantly affect cardiovascular safety, but if abnormal symptoms occur during use, consult medical personnel immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best stored at a temperature between 1 and 30 degrees Celsius at room temperature. Storing it this way helps maintain the effectiveness of the medication for a longer period.
Beige, round, biconvex film-coated tablet
28 tablets/box [(14 tablets/PTP×2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Medica Korea Co., Ltd.

Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Sitagliptin Phosphate Hydrate 32.13mg
Tablet · Prescription medication
Jong Kundang Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 64.25mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
Sitagliptin Phosphate Hydrate 32.125mg
Tablet · Prescription medication
Sinpoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.